The effects of oral ibopamine in patients with mild heart failure — a double blind placebo controlled comparison to furosemide
- 15 July 1993
- journal article
- clinical trial
- Published by Elsevier in International Journal of Cardiology
- Vol. 40 (3) , 221-227
- https://doi.org/10.1016/0167-5273(93)90004-z
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Effect of Oral Milrinone on Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1991
- The Long-Term Efficacy of Ibopamine in Treating Patients with Severe Heart FailureJournal of Cardiovascular Pharmacology, 1989
- IbopamineDrugs, 1988
- Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.Heart, 1987
- Effects of long-term therapy with oral ibopamine on resting hemodynamics and exercise capacity in patients with heart failure: relationship to the generation of N-methyldopamine and to plasma norepinephrine levels.Circulation, 1986
- Oral amrinone for the treatment of chronic congestive heart failure: Results of a multicenter randomized double-blind and placebo-controlled withdrawal studyJournal of the American College of Cardiology, 1984
- The Dopamine Congener, Ibopamine, in Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1984
- A placebo-controlled trial of captopril in refractory chronic congestive heart failureJournal of the American College of Cardiology, 1983
- Long-Term Digitalis Therapy Improves Left Ventricular Function in Heart FailureNew England Journal of Medicine, 1980
- Treadmill exercise in assessment of the functional capacity of patients with cardiac diseaseThe American Journal of Cardiology, 1972